Tesamorelin is a synthetic growth hormone-releasing factor (GHRF) analog.
Its primary medical use is to reduce the amount of excess abdominal fat (visceral adipose tissue) in adults with Human Immunodeficiency Virus (HIV) who have developed lipodystrophy. Lipodystrophy is a condition characterized by abnormal fat redistribution and metabolic changes often associated with antiretroviral therapy for HIV.
Read More DetailsThe information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.